Nicotine metabolism: the impact of CYP2A6 on estimates of additive genetic influenceSWAN, Gary E; BENOWITZ, Neal L; LESSOV, Christina N et al.Pharmacogenetics (London). 2005, Vol 15, Num 2, pp 115-125, issn 0960-314X, 11 p.Article

Vitamin D receptor genotypes influence the success of calcitriol therapy for recurrent vertebral fracture in osteoporosisMORRISON, Nigel A; GEORGE, Peter M; VAUGHAN, Tanya et al.Pharmacogenetics (London). 2005, Vol 15, Num 2, pp 127-135, issn 0960-314X, 9 p.Article

Human UGT1A6 pharmacogenetics: identification of a novel SNP, characterization of allele frequencies and functional analysis of recombinant allozymes in human liver tissue and in cultured cellsNAGAR, Swati; ZALATORIS, Jeffrey J; BLANCHARD, Rebecca L et al.Pharmacogenetics (London). 2004, Vol 14, Num 8, pp 487-499, issn 0960-314X, 13 p.Article

Identification and functional characterization of the natural variant MRP3-Arg¹²⁹⁷ His of human multidrug resistance protein 3 (MRP3/ABCC3)LEE, Young-Min A; YUNHAI CUI; KÖNIG, Jörg et al.Pharmacogenetics (London). 2004, Vol 14, Num 4, pp 213-223, issn 0960-314X, 11 p.Article

Impact of CYP2D6 intermediate metabolizer alleles on single-dose desipramine pharmacokineticsFURMAN, Katherine D; GRIMM, David R; MUELLER, Toby et al.Pharmacogenetics (London). 2004, Vol 14, Num 5, pp 279-284, issn 0960-314X, 6 p.Article

Pharmacogenetic roles of CYP2C19 and CYP2B6 in the metabolism of R- and S-mephobarbital in humansKOBAYASHI, Kaoru; MORITA, Jun; CHIBA, Kan et al.Pharmacogenetics (London). 2004, Vol 14, Num 8, pp 549-556, issn 0960-314X, 8 p.Article

The effect of rare human sequence variants on the function of vesicular monoamine transporter 2BURMAN, Jonathon; TRAN, Cindy H; GLATT, Charles et al.Pharmacogenetics (London). 2004, Vol 14, Num 9, pp 587-594, issn 0960-314X, 8 p.Article

CYP3A5*1-carrying graft liver reduces the concentration/oral dose ratio of tacrolimus in recipients of living-donor liver transplantationGOTO, Maki; MASUDA, Satohiro; KIUCHI, Tetsuya et al.Pharmacogenetics (London). 2004, Vol 14, Num 7, pp 471-478, issn 0960-314X, 8 p.Article

Pharmacogenetics and the regulation of gene transcriptionGRANT, Denis M.Pharmacogenetics (London). 2004, Vol 14, Num 7, pp 391-393, issn 0960-314X, 3 p.Article

Complex haplotype structure of the human GNAS gene identifies a recombination hotspot centred on a single nucleotide polymorphism widely used in association studiesWANLING YANG; WHITE, Brook; SPICER, Eleanor K et al.Pharmacogenetics (London). 2004, Vol 14, Num 11, pp 741-747, issn 0960-314X, 7 p.Article

Functional analysis of single nucleotide polymorphisms of hepatic organic anion transporter OATP1B1 (OATP-C)IWAI, Megumi; SUZUKI, Hiroshi; IEIRI, Ichiro et al.Pharmacogenetics (London). 2004, Vol 14, Num 11, pp 749-757, issn 0960-314X, 9 p.Article

Functional comparison of the endothelial nitric oxide synthase Glu²⁹⁸Asp polymorphic variants in human endothelial cellsMCDONALD, Denise M; ALP, Nicholas J; CHANNON, Keith M et al.Pharmacogenetics (London). 2004, Vol 14, Num 12, pp 831-839, issn 0960-314X, 9 p.Article

Lack of association between the ITPA 94C>A polymorphism and adverse effects from azathioprineGEARRY, Richard B; ROBERTS, Rebecca L; BARCLAY, Murray L et al.Pharmacogenetics (London). 2004, Vol 14, Num 11, pp 779-781, issn 0960-314X, 3 p.Article

The T³⁴¹C (Ile114Thr) polymorphism of N-acetyltransferase 2 yields slow acetylator phenotype by enhanced protein degradationYU ZANG; SHUANG ZHAO; DOLL, Mark A et al.Pharmacogenetics (London). 2004, Vol 14, Num 11, pp 717-723, issn 0960-314X, 7 p.Article

Functional significance of a hereditary adenine insertion variant in the 5'-UTR of the endothelin-1 genePOPOWSKI, Katrin; SPERKER, Bernhard; KROEMER, Heyo K et al.Pharmacogenetics (London). 2003, Vol 13, Num 8, pp 445-451, issn 0960-314X, 7 p.Article

G-protein β₃ subunit 825 C/T polymorphism is associated with weight gain during pregnancyDISHY, Victor; GUPTA, Simi; LANDAU, Ruth et al.Pharmacogenetics (London). 2003, Vol 13, Num 4, pp 241-242, issn 0960-314X, 2 p.Article

Laryngeal cancer risk in Caucasians is associated with alcohol and tobacco consumption but not modified by genetic polymorphisms in class I alcohol dehydrogenases ADH1B and ADH1C, and glutathione-S-transferases GSTM1 and GSTT1RISCH, Angela; RAMROTH, Heribert; RAEDTS, Vivianne et al.Pharmacogenetics (London). 2003, Vol 13, Num 4, pp 225-230, issn 0960-314X, 6 p.Article

Regulation of attention and response to therapy in dementia by butyrylcholinesteraseO'BRIEN, Kirsty K; SAXBY, Brian K; DEL SER, Teodoro et al.Pharmacogenetics (London). 2003, Vol 13, Num 4, pp 231-239, issn 0960-314X, 9 p.Article

Thiopurine S-methyltransferase pharmacogenetics: chaperone protein association and allozyme degradationLIEWEI WANG; SULLIVAN, William; TOFT, David et al.Pharmacogenetics (London). 2003, Vol 13, Num 9, pp 555-564, issn 0960-314X, 10 p.Article

ABCB1 C3435T and G2677T/A polymorphism decreased the risk for steroid-induced osteonecrosis of the femoral head after kidney transplantationASANO, Takeshi; TAKAHASHI, Kenji A; FUJIOKA, Mikihiro et al.Pharmacogenetics (London). 2003, Vol 13, Num 11, pp 675-682, issn 0960-314X, 8 p.Article

Analysis of Sepik populations of Papua New Guinea suggests an increase of CYP2C19 null allele frequencies during the colonization of MelanesiaMASTA, Andrew; LUM, J. Koji; HOMBHANJE, Francis W et al.Pharmacogenetics (London). 2003, Vol 13, Num 11, pp 697-700, issn 0960-314X, 4 p.Article

Decreased coumarin 7-hydroxylase activities and CYP2A6 expression levels in humans caused by genetic polymorphism in CYP2A6 promoter region (CYP2A6*9)KIYOTANI, Kazuma; YAMAZAKI, Hiroshi; HONDA, Goro et al.Pharmacogenetics (London). 2003, Vol 13, Num 11, pp 689-695, issn 0960-314X, 7 p.Article

A novel mutant allele of the CYP2A6 gene (CYP2A6*11) found in a cancer patient who showed poor metabolic phenotype towards tegafurDAIGO, Satoshi; TAKAHASHI, Yoshiki; NISHIOKA, Yasuhiko et al.Pharmacogenetics (London). 2002, Vol 12, Num 4, pp 299-306, issn 0960-314XArticle

Combined COMT and GST genotypes and hormone replacement therapy associated breast cancer riskMITRUNEN, Katja; KATAJA, Vesa; ESKELINEN, Matti et al.Pharmacogenetics (London). 2002, Vol 12, Num 1, pp 67-72, issn 0960-314XArticle

MDR1 single nucleotide polymorphisms: multiplicity of haplotypes and functional consequencesKIM, Richard B.Pharmacogenetics (London). 2002, Vol 12, Num 6, pp 425-427, issn 0960-314X, 3 p.Article